Nebivolol is more effective than atenolol for blood pressure variability attenuation and target organ damage prevention in L-NAME hypertensive rats.
Del Mauro JS, Prince PD, Santander Plantamura Y, Allo MA, Parola L, Fernandez Machulsky N, Morettón MA, Bin EP, González GE, Bertera FM, Carranza A, Berg G, Taira CA, Donato M, Chiappetta DA, Polizio AH, Höcht C.
Del Mauro JS, et al. Among authors: allo ma.
Hypertens Res. 2021 Jul;44(7):791-802. doi: 10.1038/s41440-021-00630-4. Epub 2021 Feb 22.
Hypertens Res. 2021.
PMID: 33612826